Velano Vascular

[ Editors' note : For sortable and searchable tables of all 2016 US and non-US approvals and clearances, check out our Approvals Tracker .] FDA granted market go-ahead for five devices via the d

Company Changes BLOOM , Kenneth J., MD To: Human Longevity Inc. , Head, Oncology & Immunotherapy (February) From: GE Healthcare, CMO, In Vitro Diagnostics, Life Sciences Phone: 858-249-7500 DA

New At The Helm Company Changes ALI , Faraz To: REGENXBIO Inc. , CBO (March) From: bluebird bio Inc., VP, Head, Global Commercial Dev. & External Affairs Phone: 240-552-8181 BLOOM , Kenneth J.

Start-Up Execs Agilis Biotherapeutics LLC Christopher J. Silber, MD To: CMO (January) From: VP, US Clinical Dev., H. Lundbeck AS Phone: 214-706-4340 C4 Therapeutics Inc. Jason Fisherman, MD